Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis
Open Access
- 27 August 2010
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 10 (9), 2026-2032
- https://doi.org/10.1111/j.1600-6143.2010.03225.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Six-Month Prophylaxis Is Cost Effective in Transplant Patients at High Risk for Cytomegalovirus InfectionJournal of the American Society of Nephrology, 2009
- Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant RecipientsAmerican Journal of Transplantation, 2009
- Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2009
- Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipientsJournal of Translational Medicine, 2008
- Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney TransplantationClinical Infectious Diseases, 2008
- A Survey of CMV Prevention Strategies After Liver TransplantationAmerican Journal of Transplantation, 2007
- Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survivalTransplant International, 2006
- A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1Transplantation, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976